IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

AH Equity Partners Bio II, L.L.C.

Q3 2022 Holdings

Filed 2022-11-14 | 4 holdings | $143.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
EQRx, Inc.Common Stock26886C107$86.3K17,438,46560.1%
Nautilus Biotechnology, Inc.(NAUT)Common Stock63909J108$34.6K16,298,00624.1%
Erasca, Inc.(ERAS)Common Stock29479A108$19.5K2,500,00013.6%
InVitae Corporation(NVTA1EUR)Common Stock46185L103$3.1K1,276,5412.2%